Martek licenses
This article was originally published in The Tan Sheet
Executive Summary
Martek has licensed its proprietary blend of long-chain polyunsaturated fatty acids to infant formula companies Pasteur Milk and Semper AB, the Columbia, Md.-based firm announces Aug. 16. Martek's nutritional oils are the only sources of docosahexaenoic acid (DHA) and arachidonic acid (ARA) cleared by FDA for use in formula, Martek notes. Pasteur's license agreement covers South Korea, while Semper's covers Finland, Sweden, Latvia and Lithuania...
You may also be interested in...
Martek supply deals
Swiss firms Hero Group and Hochdorf Nutricare will use docosahexaenoic and arachidonic fatty acid only from Martek Biosciences in their food products, the supplier says. Hero will add Martek's oils to its infant formula products, weaning foods and medical foods for dietetic purposes, while Hochdorf will market formulas with Martek's ARA in China and Europe. The agreement with Hero is another step to expand Martek's international presence in the infant formula market, says Ethan Leonard, VP of pediatric nutrition for Columbia, Md.-based Martek. The firm also has supply deals with Hero subsidiaries Beech-Nut and Semper, which use DHA and ARA for infant formulas sold in Finland, Latvia, Lithuania and Sweden (1"The Tan Sheet" Aug. 22, 2005, In Brief)
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.